Assessing the genomic feature of Chinese patients with ampullary adenocarcinoma: Potential therapeutic targets

Ampullary adenocarcinoma (AMPAC) is a rare malignancy, treated as pancreatic or intestinal cancer based on its histologic subtype. Little is known about the genomic features of Chinese patients with AMPAC.